UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cellular RNA binding proteins NS1-BP and hnRNP K regulate influenza A virus RNA splicing

PLoS pathogens, 2013-06, Vol.9 (6), p.e1003460-e1003460

2013

Volltextzugriff (PDF)

DNA Tumor Virus Regulation of Host DNA Methylation and Its Implications for Immune Evasion and Oncogenesis

Viruses, 2018-02, Vol.10 (2), p.82

2018

Volltextzugriff (PDF)

Influenza virus differentially activates mTORC1 and mTORC2 signaling to maximize late stage replication

PLoS pathogens, 2017-09, Vol.13 (9), p.e1006635

2017

Volltextzugriff (PDF)

Multiple host barriers restrict poliovirus trafficking in mice

PLoS pathogens, 2008-06, Vol.4 (6), p.e1000082-e1000082

2008

Volltextzugriff (PDF)

Nuclear imprisonment: viral strategies to arrest host mRNA nuclear export

Viruses, 2013-07, Vol.5 (7), p.1824-1849

2013

Volltextzugriff (PDF)

NOD1 and NOD2 Activation by Diverse Stimuli: a Possible Role for Sensing Pathogen-Induced Endoplasmic Reticulum Stress

Infection and immunity, 2020-06, Vol.88 (7)

2020

Volltextzugriff (PDF)

Sec13 Regulates Expression of Specific Immune Factors Involved in Inflammation In Vivo

Scientific reports, 2015-12, Vol.5 (1), p.17655-17655, Article 17655

2015

Volltextzugriff (PDF)

IRE1α-Driven Inflammation Promotes Clearance of Citrobacter rodentium Infection

Infection and immunity, 2022-01, Vol.90 (1), p.e0048121-e0048121

2022

Volltextzugriff (PDF)

MALDI-TOF mass spectrometry from nucleic acid: development and evaluation of a novel platform for identification of mycobacteria and detection of genetic markers of resistance

Microbiology spectrum, 2024-08, p.e0163824

2024

Volltextzugriff (PDF)

Cellular RNA Binding Proteins NS1-BP and hnRNP K Regulate Influenza A Virus RNA Splicing: e1003460

PLoS pathogens, 2013-06, Vol.9 (6)

2013

Volltextzugriff (PDF)

Multiple Host Barriers Restrict Poliovirus Trafficking in Mice: e1000082

PLoS pathogens, 2008-06, Vol.4 (6)

2008

Volltextzugriff (PDF)

Pathogenic Mutations Conferring α1-Antitrypsin Deficiency Are Identified Accurately by a Novel Multiplexed Molecular Assay

CHEST pulmonary, 2024-07, p.100076, Article 100076

2024

Volltextzugriff (PDF)

Chapter 16 - Creating Application Materials, Applying, and Interviewing for Jobs

ReSearch, 2017, p.195-232

2017

Volltextzugriff (PDF)

Ibrutinib Plus Venetoclax for First-Line Treatment of Chronic Lymphocytic Leukemia: Primary Analysis Results From the Minimal Residual Disease Cohort of the Randomized Phase II CAPTIVATE Study

Journal of clinical oncology, 2021-12, Vol.39 (34), p.3853-3865

2021

Volltextzugriff (PDF)

Fixed-duration ibrutinib plus venetoclax for first-line treatment of CLL: primary analysis of the CAPTIVATE FD cohort

Blood, 2022-06, Vol.139 (22), p.3278-3289

2022

Volltextzugriff (PDF)

Mutation of the conserved polyadenosine RNA binding protein, ZC3H14/dNab2, impairs neural function in Drosophila and humans

Proceedings of the National Academy of Sciences - PNAS, 2011-07, Vol.108 (30), p.12390-12395

2011

Volltextzugriff (PDF)

Fixed-duration (FD) ibrutinib (I) + venetoclax (V) for first-line (1L) treatment (tx) of chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL): Three-year follow-up from the FD cohort of the phase 2 CAPTIVATE study

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.7519-7519

2022

Volltextzugriff (PDF)

Fixed-duration (FD) first-line treatment (tx) with ibrutinib (I) plus venetoclax (V) for chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL): Primary analysis of the FD cohort of the phase 2 captivate study

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.7501-7501

2021

Volltextzugriff (PDF)

Antibodies targeting the PfRH1 binding domain inhibit invasion of Plasmodium falciparum merozoites

PLoS pathogens, 2008-07, Vol.4 (7), p.e1000104-e1000104

2008

Volltextzugriff (PDF)

Chronic lymphocytic leukaemia Australasian consensus practice statement

Internal medicine journal, 2023-09, Vol.53 (9), p.1678-1691

2023

Volltextzugriff (PDF)

A Pharmacokinetic Study of Intramuscular (IM) Parecoxib Sodium in Normal Subjects

Journal of clinical pharmacology, 2001-10, Vol.41 (10), p.1111-1119

2001

Volltextzugriff (PDF)

Antibodies Targeting the PfRH1 Binding Domain Inhibit Invasion of Plasmodium falciparum Merozoites: e1000104

PLoS pathogens, 2008-07, Vol.4 (7)

2008

Volltextzugriff (PDF)

A Pharmacokinetic Study of Intramuscular (IM) Parecoxib Sodium in Normal Subjects

Journal of clinical pharmacology, 2001-10, Vol.41 (10), p.1111-1119

2001

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Aktive Filter

SpracheJapanisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(23)
Buchkapitel
(1)

Sprache

Englisch
(24)

Erscheinungsjahr

n.n

Thema

Science & Technology
(15)
Life Sciences & Biomedicine
(13)
Humans
(8)
Animals
(7)
Proteins
(6)
Virology
(6)
Viruses
(6)
Microbiology
(5)
Experiments
(4)
Parasitology
(4)
Adult
(3)
Infections
(3)
Influenza
(3)
Male
(3)
Mutation
(3)
Nuclear Proteins - Genetics
(3)
Adenine - Analogs & Derivatives
(2)
Adolescent
(2)
Bottlenecks
(2)
Bridged Bicyclo Compounds, Heterocyclic - Therapeutic Use
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Cellular RNA binding proteins NS1-BP and hnRNP K regulate influenza A virus RNA splicing

DNA Tumor Virus Regulation of Host DNA Methylation and Its Implications for Immune Evasion and Oncogenesis

Influenza virus differentially activates mTORC1 and mTORC2 signaling to maximize late stage replication

Multiple host barriers restrict poliovirus trafficking in mice

Nuclear imprisonment: viral strategies to arrest host mRNA nuclear export

NOD1 and NOD2 Activation by Diverse Stimuli: a Possible Role for Sensing Pathogen-Induced Endoplasmic Reticulum Stress

Sec13 Regulates Expression of Specific Immune Factors Involved in Inflammation In Vivo

IRE1α-Driven Inflammation Promotes Clearance of Citrobacter rodentium Infection

MALDI-TOF mass spectrometry from nucleic acid: development and evaluation of a novel platform for identification of mycobacteria and detection of genetic markers of resistance

Cellular RNA Binding Proteins NS1-BP and hnRNP K Regulate Influenza A Virus RNA Splicing: e1003460

Multiple Host Barriers Restrict Poliovirus Trafficking in Mice: e1000082

Pathogenic Mutations Conferring α1-Antitrypsin Deficiency Are Identified Accurately by a Novel Multiplexed Molecular Assay

Chapter 16 - Creating Application Materials, Applying, and Interviewing for Jobs

Ibrutinib Plus Venetoclax for First-Line Treatment of Chronic Lymphocytic Leukemia: Primary Analysis Results From the Minimal Residual Disease Cohort of the Randomized Phase II CAPTIVATE Study

Fixed-duration ibrutinib plus venetoclax for first-line treatment of CLL: primary analysis of the CAPTIVATE FD cohort

Mutation of the conserved polyadenosine RNA binding protein, ZC3H14/dNab2, impairs neural function in Drosophila and humans

Fixed-duration (FD) ibrutinib (I) + venetoclax (V) for first-line (1L) treatment (tx) of chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL): Three-year follow-up from the FD cohort of the phase 2 CAPTIVATE study

Fixed-duration (FD) first-line treatment (tx) with ibrutinib (I) plus venetoclax (V) for chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL): Primary analysis of the FD cohort of the phase 2 captivate study

Antibodies targeting the PfRH1 binding domain inhibit invasion of Plasmodium falciparum merozoites

Ibrutinib (Ibr) Plus Venetoclax (Ven) for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL): 1-Year Disease-Free Survival (DFS) Results From the MRD Cohort of the Phase 2 CAPTIVATE Study

Chronic lymphocytic leukaemia Australasian consensus practice statement

A Pharmacokinetic Study of Intramuscular (IM) Parecoxib Sodium in Normal Subjects

Antibodies Targeting the PfRH1 Binding Domain Inhibit Invasion of Plasmodium falciparum Merozoites: e1000104

A Pharmacokinetic Study of Intramuscular (IM) Parecoxib Sodium in Normal Subjects

Aktive Filter

Suchergebnisse filtern